A branch site mutation leading to aberrant splicing of the human tyrosine hydroxylase gene in a child with a severe extrapyramidal movement disorder

被引:38
作者
Janssen, RJRJ
Wevers, RA
Häussler, M
Luyten, JAFM
Steenbergen-Spanjers, GCH
Hoffmann, GF
Nagatsu, T
Van den Heuvel, LPWJ
机构
[1] Univ Nijmegen, Ctr Med, Lab Pediat & Neurol, Nijmegen, Netherlands
[2] Fruehdiagnoszentrum Wuerzburg, Ctr Children Dev Disorders & Handicaps, Wurzburg, Germany
[3] Univ Pediat Hosp, Dept Pediat 1, Heidelberg, Germany
[4] Fujita Hlth Univ, Inst Comprehens Med Sci, Div Mol Genet Neurochem, Toyoake, Aichi, Japan
关键词
D O I
10.1046/j.1469-1809.2000.6450375.x
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
We report a branch site mutation in the gene of the enzyme tyrosine hydroxylase (TH): a - 24t > a substitution two bases upstream of the adenosine in the branchpoint sequence (BPS) of intron 11. As normal lariat formation is therefore prevented, alternative splicing takes place. use of the BPS of intron 12 results in skipping of exon 12, whereas the use of a cryptic branch site in intron 11 leads to partial retention of this intron in the mRNA. This leads in both cases to an aberrant protein product. In the one case, skipping of exon 12 results in the absence of 32 amino acids. In the other, retention of 36 nucleotides of intron 11 in the mRNA results in the incorporation of twelve additional amino acids. The functional consequences of this mutation for the patient, who is also heterozygous for another previously identified mutation, become apparent in a severe clinical phenotype.
引用
收藏
页码:375 / 382
页数:8
相关论文
共 27 条
[1]  
Bräutigam C, 1999, CLIN CHEM, V45, P2073
[2]  
Bräutigam C, 1998, CLIN CHEM, V44, P1897
[3]   A point mutation in an intronic branch site results in aberrant splicing of COL5A1 and in Ehlers-Danlos syndrome type II in two British families [J].
Burrows, NP ;
Nicholls, AC ;
Richards, AJ ;
Luccarini, C ;
Harrison, JB ;
Yates, JRW ;
Pope, FM .
AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 63 (02) :390-398
[4]   PREDICTION OF PROTEIN CONFORMATION [J].
CHOU, PY ;
FASMAN, GD .
BIOCHEMISTRY, 1974, 13 (02) :222-245
[5]   Tyrosine hydroxylase deficiency with severe clinical course:: Clinical and biochemical investigations and optimization of therapy [J].
Dionisi-Vici, C ;
Hoffmann, GF ;
Leuzzi, V ;
Hoffken, H ;
Bräutigam, C ;
Rizzo, C ;
Steebergen-Spanjers, GCH ;
Smeitink, JAM ;
Wevers, RA .
JOURNAL OF PEDIATRICS, 2000, 136 (04) :560-562
[6]  
Dumas S, 1996, J NEUROCHEM, V67, P19
[7]   Crystal structure of tyrosine hydroxylase at 2.3 angstrom and its implications for inherited neurodegenerative diseases [J].
Goodwill, KE ;
Sabatier, C ;
Marks, C ;
Raag, R ;
Fitzpatrick, PF ;
Stevens, RC .
NATURE STRUCTURAL BIOLOGY, 1997, 4 (07) :578-585
[8]   PRE-MESSENGER-RNA SPLICING [J].
GREEN, MR .
ANNUAL REVIEW OF GENETICS, 1986, 20 :671-708
[9]   HEREDITARY PROGRESSIVE DYSTONIA WITH MARKED DIURNAL FLUCTUATION CAUSED BY MUTATIONS IN THE GTP CYCLOHYDROLASE-I GENE [J].
ICHINOSE, H ;
OHYE, T ;
TAKAHASHI, E ;
SEKI, N ;
HORI, T ;
SEGAWA, M ;
NOMURA, Y ;
ENDO, K ;
TANAKA, H ;
TSUJI, S ;
FUJITA, K ;
NAGATSU, T .
NATURE GENETICS, 1994, 8 (03) :236-242
[10]   RECESSIVELY INHERITED L-DOPA-RESPONSIVE DYSTONIA CAUSED BY A POINT MUTATION (Q381K) IN THE TYROSINE-HYDROXYLASE GENE [J].
KNAPPSKOG, PM ;
FLATMARK, T ;
MALLET, J ;
LUDECKE, B ;
BARTHOLOME, K .
HUMAN MOLECULAR GENETICS, 1995, 4 (07) :1209-1212